Mark Jean Gnoth

This inventor holds 27 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 21 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Seattle Genetics, Inc.. Active years: 2011-2020.

USPTO Granted Patents = 27 (Patent Applications = 19)

% Patents Active = 7.4

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 21 (Patent Applications = 33)

Average Co-Inventor Count = 10.0

ph-index = 6

Forward Citations = 140(Granted Patents)

Location History:

Mettman, DE (2012 - 2016)
Mettmann, DE (2011 - 2020)

Company Filing History:

24 out of 721

Bayer Intellectual Property Gmbh

patents

5 out of 380

Bayer Pharma Aktiengesellschaft

patents

1 out of 132

Seattle Genetics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2020

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases (2020-03-31),

2. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases (2019-04-23),

3. 9962389 - 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group (2018-05-08),

4. 9730929 - Substituted aminoimidazopyridazines (2017-08-15),

5. 9669034 - 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group (2017-06-06),

6. 9643953 - Substituted benzylpyrazoles (2017-05-09),

7. 9499547 - Amino-substituted imidazopyridazines (2016-11-22),

8. 9434731 - Imidazo-, pyrazolopyrazines and imidazotriazines and their use (2016-09-06),

9. 9320737 - Substituted imidazopyridazines (2016-04-26),

10. 9284319 - Heterocyclyl aminoimidazopyridazines (2016-03-15),

11. 9051323 - Substituted imidazopyrimidines and triazolopyrimidines (2015-06-09),

12. 9029406 - N-carboxyalkylauristatins and use thereof (2015-05-12),

13. 8987248 - Substituted piperidines as Par-1 antagonists (2015-03-24),

14. 8916557 - Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines (2014-12-23),

15. 8846934 - Substituted oxazolidinones and their use (2014-09-30),

Title: The Innovative Journey of Mark Jean Gnoth

Introduction:

Mark Jean Gnoth, a talented inventor hailing from Mettmann, Germany, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

Mark Jean Gnoth's latest patents include cutting-edge innovations in the fields of renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights:

Throughout his illustrious career, Mark Jean Gnoth has been recognized for his exceptional problem-solving skills and innovative thinking. His inventions have revolutionized various industries, earning him a reputation as a visionary inventor.

Collaborations:

Mark Jean Gnoth has collaborated with leading technology companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion:

In conclusion, Mark Jean Gnoth's passion for innovation and dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.